4.7 Article

Co-Expression of Chromatin Assembly Factor 1 Subunit A and Proliferating Cell Nuclear Antigen Is a Prognostic Biomarker of Esophageal Cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Cell Biology

Cell cycle control in cancer

Helen K. Matthews et al.

Summary: This review highlights the importance of cell cycle regulation in preventing genetic errors and cell proliferation, and how disruption of these mechanisms is associated with cancer development. Cancer arises from continuous cell division and evasion of cell cycle control mechanisms.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2022)

Review Biochemistry & Molecular Biology

To skip or not to skip: choosing repriming to tolerate DNA damage

Annabel Quinet et al.

Summary: Accurate DNA replication is constantly threatened by DNA lesions from various sources, and specialized DNA replication stress response pathways ensure replication fork progression in the presence of these lesions. These pathways include translesion DNA synthesis, template switching, and replication fork repriming, with the fine-tuned balance between them being crucial for genome integrity and cell fitness.

MOLECULAR CELL (2021)

Review Biochemistry & Molecular Biology

The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment

Henry Rodriguez et al.

Summary: Proteogenomics plays a crucial role in precision oncology, offering more accurate methods for the diagnosis and treatment of tumors. The full integration of proteogenomics into clinical trials and patient care is necessary for precision oncology to deliver the right cancer treatment to the right patient at the right dose and at the right time.
Article Multidisciplinary Sciences

Large-scale and high-resolution mass spectrometry-based proteomics profiling defines molecular subtypes of esophageal cancer for therapeutic targeting

Wei Liu et al.

Summary: Proteomic analysis identified two molecular subtypes of esophageal cancer, with the S2 subtype being more aggressive and associated with a potential therapeutic outlook provided by a subtype diagnostic and prognostic model.

NATURE COMMUNICATIONS (2021)

Review Oncology

Challenging, Accurate and Feasible: CAF-1 as a Tumour Proliferation Marker of Diagnostic and Prognostic Value

Alexandros G. Sykaras et al.

Summary: The identification of new biomarkers with diagnostic, prognostic, and therapeutic value is a major challenge in current cancer research, with the assessment of tumour cell proliferative capacity being crucial for grading and clinical decision-making. The chromatin assembly factor 1 (CAF-1) has emerged as a proliferation marker of clinical importance, showing correlation with Ki-67 expression and potential relevance in cancer stratification and clinical guidance.

CANCERS (2021)

Review Cell Biology

Plectin in Cancer: From Biomarker to Therapeutic Target

Samantha M. Perez et al.

Summary: Plectin, a cytolinker and scaffolding protein, has been identified as a potent driver of malignant hallmarks in various human cancers due to its involvement in key cellular activities contributing to tumorigenesis. Targeting plectin and cancer-specific plectin (CSP) presents an attractive opportunity to directly impede carcinogenesis, with recent evidence highlighting the potential of cell-surface mislocalized proteins as novel therapeutic targets for cancer treatment.
Review Pathology

Prognostic and therapeutic molecular markers in the clinical management of esophageal cancer

Nicolas Zhou et al.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2020)

Review Biochemistry & Molecular Biology

Advances in targeted therapy for esophageal cancer

Yan-Ming Yang et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Article Multidisciplinary Sciences

Metascape provides a biologist-oriented resource for the analysis of systems-level datasets

Yingyao Zhou et al.

NATURE COMMUNICATIONS (2019)

Review Oncology

Deciphering the cells of origin of squamous cell carcinomas

Adriana Sanchez-Danes et al.

NATURE REVIEWS CANCER (2018)

Review Medicine, General & Internal

Oesophageal cancer

Jesper Lagergren et al.

LANCET (2017)

Article Multidisciplinary Sciences

Integrated genomic characterization of oesophageal carcinoma

Jihun Kim et al.

NATURE (2017)

Review Genetics & Heredity

The impact of replication stress on replication dynamics and DNA damage in vertebrate cells

Herve Techer et al.

NATURE REVIEWS GENETICS (2017)

Article Medicine, General & Internal

Oesophageal cancer

Elizabeth C. Smyth et al.

NATURE REVIEWS DISEASE PRIMERS (2017)

Article Gastroenterology & Hepatology

Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis

Basile Njei et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)

Article Genetics & Heredity

Genomic Analyses Reveal Mutational Signatures and Frequently Altered Genes in Esophageal Squamous Cell Carcinoma

Ling Zhang et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2015)

Editorial Material Gastroenterology & Hepatology

Prognostic markers in esophageal cancer: from basic research to clinical use

Liu Hong et al.

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2015)

Article Oncology

Cancer survival in China, 2003-2005: A population- based study

Hongmei Zeng et al.

INTERNATIONAL JOURNAL OF CANCER (2015)

Article Multidisciplinary Sciences

Identification of genomic alterations in oesophageal squamous cell cancer

Yongmei Song et al.

NATURE (2014)

Article Genetics & Heredity

Genomic and molecular characterization of esophageal squamous cell carcinoma

De-Chen Lin et al.

NATURE GENETICS (2014)

Review Cell Biology

Regulation of PCNA-protein interactions for genome stability

Niels Mailand et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)

Article Oncology

Oesophageal cancer survival in Europe: A EUROCARE-4 study

A. T. Gavin et al.

CANCER EPIDEMIOLOGY (2012)

Article Biochemistry & Molecular Biology

ATR activation and replication fork restart are defective in FANCM-deficient cells

Rebekka A. Schwab et al.

EMBO JOURNAL (2010)

Review Pharmacology & Pharmacy

14-3-3ζ as a prognostic marker and therapeutic target for cancer

Christopher L. Neal et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2010)

Review Biochemistry & Molecular Biology

PCNA, the maestro of the replication fork

George-Lucian Moldovan et al.